SANDOZ 78-54 (Methergine 0.2 mg)
Generic Name: methylergonovine
Pill imprint SANDOZ 78-54 has been identified as Methergine 0.2 mg.
Methergine is used in the treatment of postpartum bleeding; migraine and belongs to the drug class uterotonic agents. Risk cannot be ruled out during pregnancy. Methergine 0.2 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- SANDOZ 78-54
- 0.2 mg
- 6.00 mm
- Prescription only
- Drug Class:
- Uterotonic agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
D&C Red No. 7
FD&C Blue No. 1
|NDC Code||Manufacturer / Repackager|
|54569-0973||A-S Medication Solutions, LLC (repackager)|
|55289-0708||PDRX Pharmaceuticals Inc (repackager)|
|66336-0402||Dispensing Solutions Inc. (repackager)|
|55045-1707||Dispensing Solutions Inc. (repackager)|
|68258-9121||Dispensing Solutions Inc. (repackager)|
|43063-0147||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about Methergine (methylergonovine)
- Methergine tablets
- Methergine oral and injection
- Methergine (Advanced Reading)
- Methergine Injection (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.